-
Something wrong with this record ?
Synthetic polyamine BPA-C8 inhibits TGF-β1-mediated conversion of human dermal fibroblast to myofibroblasts and establishment of galectin-1-rich extracellular matrix in vitro
A. Mifková, O. Kodet, P. Szabo, J. Kučera, B. Dvořánková, S. André, G. Koripelly, HJ. Gabius, JM. Lehn, K. Smetana,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13488
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2012-06-18 to 1 year ago
- MeSH
- Actins metabolism MeSH
- Fibroblasts drug effects pathology MeSH
- Galectin 1 metabolism MeSH
- Rats MeSH
- Cells, Cultured MeSH
- Humans MeSH
- Myofibroblasts drug effects pathology MeSH
- Tumor Cells, Cultured MeSH
- Neoplasms drug therapy metabolism pathology MeSH
- Polyamines chemistry pharmacology MeSH
- Dermis cytology drug effects MeSH
- Transforming Growth Factor beta1 metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Cancer-associated fibroblasts (CAFs) play a role in the progression of malignant tumors. They are formed by conversion of fibroblasts to smooth muscle α-actin-positive (SMA-positive) myofibroblasts. Polyamines are known to change the arrangement of the actin cytoskeleton by binding to the anionic actin. We tested the effect of the synthetic polyamine BPA-C8 on the transition of human dermal fibroblasts to myofibroblasts induced either by TGF-β1 alone or by TGF-β1 together with adhesion/growth-regulatory galectin-1. Pre-existing CAFs, myofibroblasts from pancreatitis, and rat smooth muscle cells were also exposed to BPA-C8. BPA-C8 impaired myofibroblast formation from activated fibroblasts, but it had no effect on cells already expressing SMA. BPA-C8 also reduced the occurrence of an extracellular matrix around the activated fibroblasts. The reported data thus extend current insights into polyamine activity, adding interference with tumor progression to the tumor-promoting processes warranting study.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014279
- 003
- CZ-PrNML
- 005
- 20191014111424.0
- 007
- ta
- 008
- 150420s2014 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cbic.201402087 $2 doi
- 035 __
- $a (PubMed)24867251
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Mifková, Alžběta $u Institute of Anatomy, Charles University, 1st Faculty of Medicine, U Nemocnice 3, 128 00 Prague (Czech Republic); Department of Otorhinolaryngology and Head and Neck Surgery, Charles University, 1st Faculty of Medicine, V Úvalu 5, 150 00 Prague (Czech Republic). $7 xx0228870
- 245 10
- $a Synthetic polyamine BPA-C8 inhibits TGF-β1-mediated conversion of human dermal fibroblast to myofibroblasts and establishment of galectin-1-rich extracellular matrix in vitro / $c A. Mifková, O. Kodet, P. Szabo, J. Kučera, B. Dvořánková, S. André, G. Koripelly, HJ. Gabius, JM. Lehn, K. Smetana,
- 520 9_
- $a Cancer-associated fibroblasts (CAFs) play a role in the progression of malignant tumors. They are formed by conversion of fibroblasts to smooth muscle α-actin-positive (SMA-positive) myofibroblasts. Polyamines are known to change the arrangement of the actin cytoskeleton by binding to the anionic actin. We tested the effect of the synthetic polyamine BPA-C8 on the transition of human dermal fibroblasts to myofibroblasts induced either by TGF-β1 alone or by TGF-β1 together with adhesion/growth-regulatory galectin-1. Pre-existing CAFs, myofibroblasts from pancreatitis, and rat smooth muscle cells were also exposed to BPA-C8. BPA-C8 impaired myofibroblast formation from activated fibroblasts, but it had no effect on cells already expressing SMA. BPA-C8 also reduced the occurrence of an extracellular matrix around the activated fibroblasts. The reported data thus extend current insights into polyamine activity, adding interference with tumor progression to the tumor-promoting processes warranting study.
- 650 _2
- $a aktiny $x metabolismus $7 D000199
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a škára $x cytologie $x účinky léků $7 D020405
- 650 _2
- $a fibroblasty $x účinky léků $x patologie $7 D005347
- 650 _2
- $a galektin 1 $x metabolismus $7 D037483
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a myofibroblasty $x účinky léků $x patologie $7 D058628
- 650 _2
- $a nádory $x farmakoterapie $x metabolismus $x patologie $7 D009369
- 650 _2
- $a polyaminy $x chemie $x farmakologie $7 D011073
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a transformující růstový faktor beta1 $x metabolismus $7 D053773
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kodet, Ondřej, $d 1983- $7 xx0170115
- 700 1_
- $a Szabo, Pavol $7 xx0145899
- 700 1_
- $a Kučera, Jan $7 xx0228147
- 700 1_
- $a Dvořánková, Barbora, $d 1955- $7 xx0076196
- 700 1_
- $a André, Sabine $7 gn_A_00006374
- 700 1_
- $a Koripelly, Girish
- 700 1_
- $a Gabius, Hans-Joachim
- 700 1_
- $a Lehn, Jean-Marie
- 700 1_
- $a Smetana, Karel, $d 1958- $7 jn20000710554
- 773 0_
- $w MED00006594 $t Chembiochem a European journal of chemical biology $x 1439-7633 $g Roč. 15, č. 10 (2014), s. 1465-1470
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24867251 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20191014111848 $b ABA008
- 999 __
- $a ok $b bmc $g 1071860 $s 897157
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 15 $c 10 $d 1465-1470 $i 1439-7633 $m Chembiochem $n Chembiochem $x MED00006594
- GRA __
- $a NT13488 $p MZ0
- LZP __
- $a Pubmed-20150420